Fatty liver disease

A new dataset from genomics company Helix aims to accelerate research into metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease.

In the cola wars of the 1980s, Coke and Pepsi went head-to-head in taste tests to “prove” which was America’s favorite. I was a Coke…

The first healthy volunteers have been dosed in a Phase 1 clinical trial testing a combination therapy for metabolic dysfunction-associated steatohepatitis (MASH), a severe form…

A family whose experience with biliary atresia led to an effort to help others navigate the challenges of pediatric liver disease is among those being…

One of the hardest parts of living with metabolic dysfunction-associated steatohepatitis (MASH) is carrying regrets about the past. The first time your doctor noticed…

The American Liver Foundation (ALF) is launching a first-of-its kind national database, called the ALF Living Donor Network, to connect people willing to…

A combination of pemafibrate and telmisartan, two medications approved in some countries to help manage cardiovascular conditions, may help reduce the buildup of liver fat…

October is National Liver Awareness Month and Liver Cancer Awareness Month, and advocacy organizations across the U.S., including the American Liver Foundation (ALF), are…

This morning I woke up to a changed forest outside my window. I live in a beautiful park in Baltimore, and I bought my house…

High blood pressure is a leading cardiometabolic risk factor — a condition linked to problems such as heart disease, stroke, and diabetes — associated with…